NIPH Clinical Trials Search

Joint Ehime-Tokushima Advanced Rehabilitation to Optimize User-friendly Nakayama Dementia prevention

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	dementia
Date of first enrollment	01/07/2024
Target sample size	84
Countries of recruitment
Study type	Interventional
Intervention(s)	The subjects will participate in the Exerpo rehabilitation programme run by the Institute of Biomedical Sciences, Tokushima University, and will perform exercises (60 minutes per day) 1 to 3 days per week. They will also be free to use the lifestyle support and health equipment. There will be no restrictions on use (however, Exerpo will be limited to around 1 hour per day), and each person will use the equipment for the period and according to the symptoms they wish to treat.

Outcome(s)

Primary Outcome	Evaluation of the effectiveness of rehabilitation Evaluation will be carried out as a day service. A comparison will be made between before participation (0 months) and after participation (12 months). The evaluation items are MMSE (cognitive function score).
Secondary Outcome	Data such as TUG, gait, gait pattern, balance (motor function data), BI, IADL, EQ-5D (ADL and QOL data), NPI (psychiatric symptom score), Pittsburgh Sleep Quality Index (sleep score), VAS (pain score), PGIC (day service satisfaction) will be compared and analysed at 12-month intervals.

Key inclusion & exclusion criteria

Age minimum	>= 65age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients with dementia who are currently using the day services at Nakayama Koubaien, Saretani Office, and Nonaka Office in Ehime Prefecture. As an example of the severity of the condition, patients with dementia who are able to move their limbs and sit up by themselves and who are able to participate in cognitive rehabilitation and exercise. The study will be conducted at the three facilities of Nakayama Koubaien, Saretani Office, and Nonaka Office. The subjects are patients with dementia who are participating in the day service at Nakayama Koubaien and who have volunteered to participate in the Exerpo, and who have given their informed consent. They will be registered in the intervention group in turn. The control group will be made up of patients who are participating in the same day service at the Nakayama Koubaien branch centres of Saretani and Nonaka, and who have given their informed consent. They will be registered in the control group, which will use the regular day service and not the Exerpo, in turn.
Exclude criteria	If the candidate does not provide written consent If the candidate is deemed unsuitable to participate in the test